Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

ALTO-100 in Bipolar Disorder With Depression (BD-D)

ClinicalTrials.gov ID: NCT06656416

Public ClinicalTrials.gov record NCT06656416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study Followed by Open-Label Treatment of ALTO-100 in Adults With Bipolar Disorder Currently Experiencing a Major Depressive Episode

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depressive episode, when used adjunctively to a mood stabilizer and/or atypical antipsychotic, related to patient characteristics. Additionally, safety, tolerability, and efficacy will be assessed in a subsequent open label treatment period.

Study identification

NCT ID
NCT06656416
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alto Neuroscience
Industry
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2, 2024 (Actual)
Primary completion
Sep 2027 (Estimated)
Completion
Oct 2027 (Estimated)
Last update posted
Oct 13, 2026

2024 – 2027

United States locations

U.S. sites
58
U.S. states
24
U.S. cities
51
Facility City State ZIP Site status
Site 6074 Birmingham Alabama 35203 Withdrawn
Site 6036 Chandler Arizona 85224 Withdrawn
Site 6000 Phoenix Arizona 85012 Recruiting
Site 6087 Yuma Arizona 85364 Withdrawn
6039 Fayetteville Arkansas 72703 Withdrawn
6070 Little Rock Arkansas 72204 Terminated
Site 6133 Little Rock Arkansas 72211 Recruiting
Site 6153 Chino California 92056 Recruiting
Site 6081 Imperial California 92251 Withdrawn
6069 Los Angeles California 90025 Recruiting
Site 6016 Mather California 95655 Recruiting
Site 6082 Oceanside California 92056 Terminated
Site 6102 Riverside California 92506 Withdrawn
Site 6111 Sacramento California 95817 Recruiting
Site 6120 San Jose California 95124 Recruiting
Site 6112 Colorado Springs Colorado 80910 Recruiting
Site 6174 Jacksonville Florida 32216 Recruiting
Site 6067 Lauderhill Florida 33319 Withdrawn
Site 6123 Pinellas Park Florida 33782 Recruiting
Site 6015 Tampa Florida 33629 Recruiting
Site 6193 Atlanta Georgia 30303 Not yet recruiting
Site 6068 Atlanta Georgia 30328 Withdrawn
Site 6064 Peachtree Corners Georgia 30071 Recruiting
Site 6113 Chicago Illinois 60611 Recruiting
Site 6132 Carmel Indiana 46032 Recruiting
Site 6101 West Lafayette Indiana 47906 Terminated
Site 6151 Baltimore Maryland 21229 Withdrawn
Site 6076 Bel Air Maryland 21015 Recruiting
Site 6062 Gaithersburg Maryland 20877 Recruiting
Site 6182 Towson Maryland 21204 Recruiting
Site 6188 Worcester Massachusetts 01608 Recruiting
Site 6184 Ann Arbor Michigan 48105 Recruiting
Site 6155 Ann Arbor Michigan 48109 Recruiting
Site 6178 Grand Rapids Michigan 49501 Recruiting
Site 6122 Flowood Mississippi 39232 Recruiting
Site 6142 Lincoln Nebraska 68526 Withdrawn
Site 6144 Las Vegas Nevada 89102 Recruiting
Site 6104 Las Vegas Nevada 89119 Recruiting
Site 6066 Toms River New Jersey 08755 Recruiting
Site 6014 Albuquerque New Mexico 87108 Recruiting
Site 6078 Albuquerque New Mexico 87110 Withdrawn
Site 6170 Amherst New York 14226 Recruiting
Site 6137 New York New York 10029 Recruiting
Site 6127 Cary North Carolina 27511 Recruiting
Site 6187 Rose Hill North Carolina 28458 Recruiting
Site 6029 Cincinnati Ohio 45215 Recruiting
6065 North Canton Ohio 44720 Terminated
Site 6075 Westlake Ohio 44145 Recruiting
Site 6116 Austin Texas 78701 Recruiting
Site 6105 Beaumont Texas 77701 Recruiting
Site 6176 Dallas Texas 75243 Recruiting
Site 6107 Dallas Texas 75251 Recruiting
Site 6175 Houston Texas 77007 Recruiting
Site 6072 Houston Texas 77081 Withdrawn
Site 6053 Plano Texas 75093 Recruiting
Site 6121 Draper Utah 84020 Withdrawn
Site 6177 Fairfax Virginia 22030 Recruiting
Site 6128 Bellevue Washington 98004 Terminated

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06656416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06656416 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →